446 related articles for article (PubMed ID: 23749968)
41. Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy.
Hsu DC; Kerr SJ; Thongpaeng P; Iampornsin T; Pett SL; Zaunders JJ; Avihingsanon A; Ubolyam S; Ananworanich J; Kelleher AD; Cooper DA
J Infect; 2014 Apr; 68(4):344-54. PubMed ID: 24325926
[TBL] [Abstract][Full Text] [Related]
42. Loss of CD4 positive T cells and evidence for impaired differentiation of both CD4 and CD8 positive T cells in the large intestine of patients infected with human immunodeficiency virus (HIV). Berlin Diarrhea/Wasting Syndrome Study Group.
Ullrich R; Schneider T; Bergs C; Schmidt W; Jahn HU; Dormann A; Zeitz M
Adv Exp Med Biol; 1995; 371B():1015-7. PubMed ID: 7502742
[No Abstract] [Full Text] [Related]
43. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
[TBL] [Abstract][Full Text] [Related]
44. The immunomodulatory nutritional intervention NR100157 reduced CD4+ T-cell decline and immune activation: a 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study).
Cahn P; Ruxrungtham K; Gazzard B; Diaz RS; Gori A; Kotler DP; Vriesema A; Georgiou NA; Garssen J; Clerici M; Lange JM;
Clin Infect Dis; 2013 Jul; 57(1):139-46. PubMed ID: 23511299
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection.
Herasimtschuk A; Downey J; Nelson M; Moyle G; Mandalia S; Sikut R; Adojaan M; Stanescu I; Gotch F; Imami N
Vaccine; 2014 Dec; 32(51):7005-7013. PubMed ID: 25454870
[TBL] [Abstract][Full Text] [Related]
46. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status.
Critchfield JW; Young DH; Hayes TL; Braun JV; Garcia JC; Pollard RB; Shacklett BL
PLoS One; 2008; 3(10):e3577. PubMed ID: 18974782
[TBL] [Abstract][Full Text] [Related]
47. Parallel studies of mucosal immunity in the reproductive and gastrointestinal mucosa of HIV-infected women.
Shanmugasundaram U; Critchfield JW; Giudice LC; Smith-McCune K; Greenblatt RM; Shacklett BL
Am J Reprod Immunol; 2020 Jul; 84(1):e13246. PubMed ID: 32301548
[TBL] [Abstract][Full Text] [Related]
48. Longitudinal analysis of distribution and function of plasmacytoid dendritic cells in peripheral blood and gut mucosa of HIV infected patients.
Lehmann C; Jung N; Förster K; Koch N; Leifeld L; Fischer J; Mauss S; Drebber U; Steffen HM; Romerio F; Fätkenheuer G; Hartmann P
J Infect Dis; 2014 Mar; 209(6):940-9. PubMed ID: 24259523
[TBL] [Abstract][Full Text] [Related]
49. Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection.
de Paula HHS; Ferreira ACG; Caetano DG; Delatorre E; Teixeira SLM; Coelho LE; João EG; de Andrade MM; Cardoso SW; Grinsztejn B; Veloso VG; Morgado MG; Guimarães ML; Côrtes FH
Retrovirology; 2018 Dec; 15(1):76. PubMed ID: 30541557
[TBL] [Abstract][Full Text] [Related]
50. The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients.
Allers K; Puyskens A; Epple HJ; Schürmann D; Hofmann J; Moos V; Schneider T
Mucosal Immunol; 2016 Jan; 9(1):265-74. PubMed ID: 26129649
[TBL] [Abstract][Full Text] [Related]
51. Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
d'Ettorre G; Baroncelli S; Micci L; Ceccarelli G; Andreotti M; Sharma P; Fanello G; Fiocca F; Cavallari EN; Giustini N; Mallano A; Galluzzo CM; Vella S; Mastroianni CM; Silvestri G; Paiardini M; Vullo V
PLoS One; 2014; 9(10):e109791. PubMed ID: 25340778
[TBL] [Abstract][Full Text] [Related]
52. HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease.
Popescu I; Drummond MB; Gama L; Lambert A; Hoji A; Coon T; Merlo CA; Wise RA; Keruly J; Clements JE; Kirk GD; McDyer JF
J Infect Dis; 2016 Nov; 214(10):1520-1530. PubMed ID: 27613775
[TBL] [Abstract][Full Text] [Related]
53. CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8+ T-cell immune activation.
Greathead L; Metcalf R; Gazzard B; Gotch F; Steel A; Kelleher P
AIDS; 2014 Jul; 28(11):1690-2. PubMed ID: 24911351
[TBL] [Abstract][Full Text] [Related]
54. IL7RA polymorphisms predict the CD4+ recovery in HIV patients on cART.
Guzmán-Fulgencio M; Berenguer J; Jiménez-Sousa MA; Micheloud D; García-Álvarez M; Bellón JM; Aldámiz-Echevarría T; García-Broncano P; Catalán P; Diez C; Pineda-Tenor D; Resino S
Eur J Clin Invest; 2015 Nov; 45(11):1192-9. PubMed ID: 26402121
[TBL] [Abstract][Full Text] [Related]
55. Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.
Gordon SN; Cervasi B; Odorizzi P; Silverman R; Aberra F; Ginsberg G; Estes JD; Paiardini M; Frank I; Silvestri G
J Immunol; 2010 Nov; 185(9):5169-79. PubMed ID: 20889546
[TBL] [Abstract][Full Text] [Related]
56. Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.
Nakanjako D; Ssinabulya I; Nabatanzi R; Bayigga L; Kiragga A; Joloba M; Kaleebu P; Kambugu AD; Kamya MR; Sekaly R; Elliott A; Mayanja-Kizza H
Trop Med Int Health; 2015 Mar; 20(3):380-90. PubMed ID: 25441397
[TBL] [Abstract][Full Text] [Related]
57. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
[TBL] [Abstract][Full Text] [Related]
58. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group.
Schneider T; Jahn HU; Schmidt W; Riecken EO; Zeitz M; Ullrich R
Gut; 1995 Oct; 37(4):524-9. PubMed ID: 7489940
[TBL] [Abstract][Full Text] [Related]
59. CD8 TCR β chain repertoire expansions and deletions are related with immunologic markers in HIV-1-infected patients during treatment interruption.
González-Serna A; Abad-Fernández M; Soriano-Sarabia N; Leal M; Vallejo A
J Clin Virol; 2013 Dec; 58(4):703-9. PubMed ID: 24210957
[TBL] [Abstract][Full Text] [Related]
60. Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy.
Sainz T; Serrano-Villar S; Mann S; Ma ZM; Utay NS; Thompson CG; Chun TW; Kashuba AD; Siewe B; Albanese A; Troia-Cancio P; Sinclair E; Somasunderam A; Yotter T; Moreno S; Pollard RB; Landay A; Miller CJ; Asmuth DM
AIDS; 2019 Dec; 33(15):2289-2298. PubMed ID: 31764094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
